Guest Post by
Experts who testified at Sen. Ron Johnson’s COVID-19 roundtable described how regulators stifled data, silenced dissenting views and made it possible for drugmakers to prioritize profits over patients under a system where “the price of the stock mattered more than the price of a life.”
Conflicts of interest between government health agencies and pharmaceutical companies fueled suppression of scientific research on issues ranging from alternative COVID-19 treatments to childhood vaccines to the controversial origins of COVID-19, experts told a Senate panel on Monday.
Experts who testified at Sen. Ron Johnson’s roundtable, “Federal Health Agencies and the COVID Cartel,” described how regulators systematically stifled data, silenced dissenting views and made it possible for drugmakers to prioritize profits over patients under a system where “the price of the stock mattered more than the price of a life,” according to Dr. Sabine Hazan, CEO of ProgenaBiome.